Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Commonly prescribed drugs could increase risk of dementia, scientists have warned. Research conducted by the University of ...

Dr James Pickett, Head of Research at Alzheimer’s Society, warned commonly-prescribed drugs that treat conditions including ...